Immunotherapy

Nanomaterials: A New Frontier in Cancer Immunotherapy

by

Researchers at Nankai University have developed a framework for integrated nanomaterials designed to overcome the physiological and immune-based barriers that frequently limit the effectiveness of cancer immunotherapy. Published April 24, 2026, in the Chinese Journal of Polymer Science, the study outlines how coordinated nanomaterial design can improve drug delivery, antigen presentation, and tumor microenvironment reprogramming … Read more

Targeting Lactylation to Overcome Cancer Therapy Resistance

by

Lactylation-driven metabolic reprogramming acts as a central driver of therapeutic resistance in cancer, according to recent findings published in the journal Genes & Diseases by researchers Wanghao Zhang, Guanglong Huang, Woheng Tang, Jiaxian Li, Jingxian Chen, Yaojiang Feng, Kaichen Li, Can Pan, Shunshen Li, Huayang Zhang, Rongxu Ye, Hao Long, and Guo-zhong Yi. This cellular … Read more

New Skin Cancer Treatment Discovery for Immunosuppressed Patients

by

Immunosuppressed patients diagnosed with non-melanoma skin cancer are not lacking vital cancer-fighting immune cells as previously believed, but rather possess macrophages that have lost their ability to communicate effectively, according to a study published in Cell by researchers at The University of Texas MD Anderson Cancer Center. The findings reveal that macrophages in patients with … Read more

Optimizing Liver Cancer Treatment via Gene Signatures and Multi-Omics

by

Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more

BCG Vaccine May Alter Human Brain Immunity

by

The Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may remodel the brain’s immune environment to potentially lower Alzheimer’s disease risk, according to research published in Communications Medicine. A year-long study led by Mass General Brigham investigators found the vaccine increased immune cell responsiveness and altered Alzheimer’s-related biomarkers in older adults without pre-existing pathology. … Read more

New Breast Cancer Classification Predicts Immunotherapy Success

by

Researchers from the Department of Breast Surgery at Fudan University Shanghai Cancer Center and the Department of Oncology at Shanghai Medical College, Fudan University have developed a new classification system for breast cancer based on the cancer-immunity cycle (CIC). Published in Cancer Biology & Medicine in 2026, this framework uses a “CIC score” to categorize … Read more

Dual-Target CAR-T Therapy: A Breakthrough for Aggressive Brain Tumors

by

Researchers at McMaster University have developed a new immunotherapy strategy that simultaneously attacks glioblastoma tumors and the immune cells that help them grow. By using Chimeric Antigen Receptor T-cell (CAR-T) therapy to target the GPNMB protein, the study—published July 1 in Nature—demonstrated the ability to eliminate detectable tumors and achieve long-term disease-free survival in pre-clinical … Read more

Probiotic Metabolite Suppresses Melanoma Growth in Mice

by

Researchers at Southern Medical University have identified that Bifidobacterium animalis, a common probiotic, secretes mannose to boost the effectiveness of melanoma immunotherapy. According to a study published in the May 2026 issue of Cancer Biology & Medicine, this sugar activates CD8⁺ T cells by targeting the Hippo-YAP1 signaling pathway, offering a potential new strategy to … Read more

Watch Immune Cells Attack Melanoma in Real Time

by

Unmasking the Body’s Hidden Defense Against Melanoma For years, medical science has focused heavily on T cells and B cells in the fight against cancer. However, groundbreaking research from the Garvan Institute of Medical Research has shifted the spotlight toward an unlikely hero: the macrophage. Often dismissed as mere “housekeepers” of the immune system, these … Read more

Small T-cell subset drives powerful multiple myeloma immunotherapy responses

by

Breakthrough in Cancer Immunotherapy: How a Tiny Fraction of T Cells Could Revolutionize Multiple Myeloma Treatment By [Your Name], Cancer Immunotherapy Research Journalist Osaka, Japan — A groundbreaking study from researchers at Osaka University has uncovered a surprising truth about how the body fights cancer: in the battle against multiple myeloma, only a small group … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]